Climates Health Tech ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Bankruptcy risk for industry  1.5% 1.5% 1.5% 1.5% 1.5%  
Bankruptcy risk  22.1% 9.4% 13.2% 10.8% 11.1%  
Credit score (0-100)  5 26 16 22 21  
Credit rating  B BB BB BB BB  
Credit limit (kDKK)  0.0 0.0 0.0 0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Gross profit  17.0 295 43.6 120 116  
EBITDA  11.0 263 -179 119 116  
EBIT  11.0 263 -179 119 116  
Pre-tax profit (PTP)  11.0 244.9 -197.5 108.1 108.4  
Net earnings  8.0 190.9 -154.1 84.3 77.6  
Pre-tax profit without non-rec. items  11.0 245 -198 108 108  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Tangible assets total  0.0 0.0 0.0 0.0 0.0  
Shareholders equity total  58.0 249 95.3 180 257  
Interest-bearing liabilities  0.0 870 656 580 197  
Balance sheet total (assets)  64.0 1,704 853 807 471  

Net Debt  -64.0 730 625 571 178  
 
See the entire balance sheet

Volume 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  17.0 295 43.6 120 116  
Gross profit growth  0.0% 1,636.7% -85.2% 175.8% -3.3%  
Employees  0 0 1 0 0  
Employee growth %  0.0% 0.0% 0.0% -100.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  64 1,704 853 807 471  
Balance sheet change%  0.0% 2,561.7% -49.9% -5.4% -41.6%  
Added value  11.0 263.1 -179.0 118.5 116.2  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  0 0 0 0 0  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 -1.0 1.0 2.0  

Profitability 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  64.7% 89.1% -411.1% 98.6% 100.0%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  17.2% 29.8% -12.8% 16.5% 19.6%  
ROI %  19.0% 44.7% -17.5% 18.1% 20.7%  
ROE %  13.8% 124.3% -89.4% 61.4% 35.5%  

Solidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Equity ratio %  90.6% 14.6% 11.2% 22.3% 54.5%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  -581.8% 277.7% -349.1% 482.1% 153.3%  
Gearing %  0.0% 348.9% 688.4% 323.0% 76.6%  
Net interest  0 0 0 0 0  
Financing costs %  0.0% 4.2% 4.5% 4.6% 4.4%  

Liquidity 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Quick Ratio  10.7 0.7 0.6 0.6 0.2  
Current Ratio  10.7 1.2 1.1 1.3 2.2  
Cash and cash equivalent  64.0 139.4 30.7 8.7 18.7  

Capital use efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  58.0 249.3 95.3 179.6 257.2  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2019/12
2020
2020/12
2021
2021/12
2022
2022/12
2023
2023/12
Net sales / employee  0 0 0 0 0  
Added value / employee  0 0 -179 0 0  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  0 0 -179 0 0  
EBIT / employee  0 0 -179 0 0  
Net earnings / employee  0 0 -154 0 0